AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Freely Filtered 028: Finerenone for diabetic kidney disease
Freely Filtered, a NephJC Podcast
Diabetic Kidney Disease - Is There a Difference Between the Two?
There was particularly in high BMI patients, an indication that the benefit was less strong in that group. There weren't any other safety outcomes really to report the safety, the adverse events were otherwise balanced between the two groups. We see an 18% spread in their primary outcome, which is 40% drop in E-GFR death by renal cause or E-S-K-D defined as a GFR lesson, 15 or dialysis. And this is despite the fact that they did not enroll anybody who had a potassium greater than 4.8,. They still found a real about 5% of patients, 4% of patients having potassium is greater than 6 at some point during the trial.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode